Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia
Condition:   Congenital Adrenal Hyperplasia (CAH) Intervention:   Sponsor:   Assistance Publique - Hôpitaux de Paris Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia
Condition:   Congenital Adrenal Hyperplasia (CAH) Intervention:   Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2018 Category: Research Source Type: clinical trials

Androgen Reduction in Congenital Adrenal Hyperplasia
Condition:   Congenital Adrenal Hyperplasia Interventions:   Drug: Abiraterone acetate;   Drug: Placebo;   Drug: Hydrocortisone;   Drug: Fludrocortisone Sponsors:   University of Texas Southwestern Medical Center;   National Institutes of Health Clinical Center (CC);   University of Michigan;   Children's Hospital Los Angeles;   Feinstein Institute for Medical Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2018 Category: Research Source Type: clinical trials